UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



(Mark One)

FORM 10 –K/A



Amendment No. 1

|x | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|- | ------------------------------------------------------------------------------------



For the fiscal year ended June
30, 2011



or



| ̈ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|- | ----------------------------------------------------------------------------------------



For the transition period from ______________ to __________________



Commission file number: 000 - 51312



SHENGTAI PHARMACEUTICAL, INC.

(Exact name of registrant as specified in
its charter )

|Delaware
        State or other jurisdiction of
        incorporation or organization |  | 54-2155579
        (I.R.S. Employer
        Identification No.)
|------------------------------------------------------------------------------------- |  | ---------------------------------------------------------------



|Changda Road East, Development
        District, Changle
        County, Shandong, People’s
        Republic of China
        Address of principal executive
        offices) |  | 262400
        (Zip Code)
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |  | -------------------------



Registrant’s telephone number, including; area code  
011 - 86 - 536 - 2188831



Securities registered pursuant to Section 12(b) of the Act:



|Title of each class | Name of each exchange on which registered
|------------------- | -----------------------------------------



Securities registered pursuant to section
12(g) of the Act:

Common Stock par value $0.001

(Title of class)



Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ̈YesxNo



Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. ̈YesxNo



Note – Checking the box above will
not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Exchange  Act from their obligations
under those Sections.



Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days.xYes ̈No



Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).oYesxNo



Indicate
by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not
contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ̈YesxNo



Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of
“large accelerated filer,” “accelerated filer,” and “smaller reporting companies” in Rule 12b-2
of the Exchange Act.



|Large accelerated filer ̈ | Accelerated filer ̈        
|------------------------ | --------------------------
|Non-accelerated filer ̈   | Smaller reporting companyx



Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). ̈YesxNo



State the aggregate market value of the
voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last
sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently
completed second fiscal quarter.



Note.— If a determination
as to whether a particular person or entity is an affiliate cannot be made without involving unreasonable effort and expense, the
aggregate market value of the common stock held by non-affiliates may be calculated on the basis of assumptions reasonable under
the circumstances, provided that the assumptions are set forth in this Form.



The aggregate market value of the voting
and non-voting common equity held by non-affiliates* computed by reference to the price of $2.90 per share of common stock at which
the common equity was last sold on December 31, 2010, the last day of our most recently completed second fiscal quarter, as reported
on www.yahoo.com was: $14,794,753.



* Excludes 5,101,693 shares of common stock
held by executive officers, directors and stockholders whose individual ownership exceeds 10% of common stock outstanding on June
30, 2011.



Note. —If a determination
as to whether a particular person or entity is an affiliate cannot be made without involving unreasonable effort and expense, the
aggregate market value of the common stock held by non-affiliates may be calculated on the basis of assumptions reasonable under
the circumstances, provided that the assumptions are set forth in this Form.



APPLICABLE ONLY TO REGISTRANTS INVOLVED
IN BANKRUPTCY

PROCEEDINGS DURING THE PRECEDING FIVE YEARS:



Indicate
by check mark whether the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the
Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. ̈Yes ̈No



(APPLICABLE ONLY TO CORPORATE REGISTRANTS)



Indicate the number of shares outstanding
of each of the registrant’s classes of common stock, as of the latest practicable date.



There were 9,584,912 shares of Common Stock,
par value $0.001, issued and outstanding as of September 27, 2011.



DOCUMENTS INCORPORATED BY REFERENCE



None.













TABLE OF CONTENTS



|                      |   |                                             |  
|--------------------- | - | ------------------------------------------- | -
|                      |  
|EXPLANATORY
    NOTE  |  
|PART III              |  
|Item 11.              |   | Executive
    Compensation                  | 1
|                      |   | Compensation
    Discussion and Analysis    | 1
|                      |   | Compensation
    Committee Report           |  
|                      |   | Compensation
    Risk Assessment            |  
|                      |   | Compensation
    Tables                     |  
|                      |  
|PART IV               |  
|Item 15.              |   | Exhibits,
    Financial Statement Schedules | 5
|INDEX TO
    EXHIBITS | 7













EXPLANATORY NOTE TO 10K/A



The purposes of this Amendment No. 1
to the Annual Report on Form 10K/A for the fiscal year ended June 30, 2011 (the “Report”) of Shengtai Pharmaceuticals,
Inc., a Nevada corporation (the “Company”), which was originally filed with the Securities and Exchange Commission
(the “SEC”) on October 7, 2011 (the “Original Filing”), to: (1) amend Part III, Item 11 to revise the
Summary Compensation Table and include disclosures on the decrease of base salaries of Mr. Qingtai Liu and Mr. Yongqiang Wang,
and (2) update the Exhibit Index and file Exhibits 10.8 and 10.9. All other information contained in the Report remains unchanged.



Except for the amendments described above,
the information in this Amendment No. 1 has not been updated to reflect events that occurred after October 7, 2011, the filing
date of the Original Filing. Accordingly, this Amendment No.1 should be read in conjunction with our filings made with the SEC
subsequent to the filing of the Original Filing, including any amendments to those filings.





PART III





Item 11.  Executive Compensation



Compensation Discussion and Analysis



We endeavor to provide our “named executive
officers,” as defined in Item 402 of Regulation S-K, with a competitive base salary that is in- line with their roles and
responsibilities when compared to peer companies of comparable size in the same or similar locality.



It is not uncommon for PRC private corporations
in that locality to have base salaries as the sole and only form of compensation. The base salary level is established and reviewed
based on the level of responsibilities, the experience and tenure of the individual and the current and potential contributions
of the individual. The base salary is compared to the list of similar positions within comparable peer companies and with consideration
of the executive’s relative experience in his or her position. Base salaries are reviewed periodically and at the time of
promotion or other changes in responsibilities.



We plan to implement a more comprehensive
compensation program, which takes into account other elements of compensation, including without limitation, short and long term
compensation, cash and non-cash, and other equity-based compensation such as stock options. This compensation program shall be
comparative to our peers in the industry and aimed to retain and attract talented individuals.



We have formed a Compensation Committee of
the Board of Directors comprised solely of independent directors to oversee the compensation of our named executive officers. The
members of our Compensation Committee are Fei He (Chairman), Yaojun Liu and Winfred Lee.  The Board has determined that
all members of the compensation committee are independent directors under the rules of the Nasdaq Stock Market or NYSE Amex, as
applicable. The compensation committee administers the Company’s benefit plans, reviews and administers all compensation
arrangements for executive officers, and establishes and reviews general policies relating to the compensation and benefits of
our officers and employees. The compensation committee operates under a written charter that is made available on the website mentioned
above.



Summary Compensation Table



The following table sets forth information
with respect to the compensation of each of the named executive officers for services provided in all capacities to the Company
in the fiscal years ended June 30, 2011 and 2010 in their capacity as such officers.  No other executive officer or former
executive officer received more than $100,000 in compensation in the fiscal years reported below.





1







|Name
    and Principal Position |  | Fiscal
    Year |      |  | Salary
    ($) |  |         | Bonus
    ($) |  |  | Stock
    Awards ($) |  |  | Option
    Awards ($) |   |  | Non-equity
    Incentive
    Plan
    Compensation
    ($) |  |        | Change
    in Pension Value and Nonqualified Deferred Compensation Earnings ($) |  |  | All
    Other
    Compensation
    ($) |  |  | Total
    ($) |  
|------------------------------- |  | --------------- | ---- |  | -------------- |  | ------- | ------------- |  |  | -------------------- |  |  | --------------------- | - |  | ---------------------------------------------------------- |  | ------ | ------------------------------------------------------------------------------- |  |  | -------------------------------------- |  |  | ------------- | -
|                                |  |                 |      |  |                |  |         |               |  |  |                      |  |  |                       |   |  |                                                            |  |        |                                                                                 |  |  |                                        |  |  |               |  
|Qintai Liu                      |  |                 | 2011 |  |                |  | 18,564  |               |  |  | —                    |  |  |                       | — |  |                                                            |  | —      |                                                                                 |  |  | —                                      |  |  |               | —
|Chairman & Chief                |  |                 |      |  |                |  |         |               |  |  |                      |  |  |                       |   |  |                                                            |  |        |                                                                                 |  |  |                                        |  |  |               |  
|Executive                       |  |                 | 2010 |  |                |  | 107,676 |               |  |  | —                    |  |  |                       | — |  |                                                            |  | —      |                                                                                 |  |  | —                                      |  |  |               | —
|Officer                         |  |                 |      |  |                |  |         |               |  |  |                      |  |  |                       |   |  |                                                            |  |        |                                                                                 |  |  |                                        |  |  |               |  
|                                |  |                 |      |  |                |  |         |               |  |  |                      |  |  |                       |   |  |                                                            |  |        |                                                                                 |  |  |                                        |  |  |               |  
|Hu Ye                           |  |                 |      |  |                |  |         |               |  |  |                      |  |  |                       |   |  |                                                            |  |        |                                                                                 |  |  |                                        |  |  |               |  
|Chief                           |  |                 | 2011 |  |                |  | 36,976  |               |  |  | —                    |  |  |                       | — |  |                                                            |  | 35,206 |                                                                                 |  |  | —                                      |  |  |               | —
|Financial                       |  |                 |      |  |                |  |         |               |  |  |                      |  |  |                       |   |  |                                                            |  |        |                                                                                 |  |  |                                        |  |  |               |  
|Officer (1)                     |  |                 | 2010 |  |                |  | 48,831  |               |  |  | —                    |  |  |                       | — |  |                                                            |  | 46,303 |                                                                                 |  |  | —                                      |  |  |               | —
|                                |  |                 |      |  |                |  |         |               |  |  |                      |  |  |                       |   |  |                                                            |  |        |                                                                                 |  |  |                                        |  |  |               |  
|Yongqiang Wang                  |  |                 |      |  |                |  |         |               |  |  |                      |  |  |                       |   |  |                                                            |  |        |                                                                                 |  |  |                                        |  |  |               |  
|Chief                           |  |                 | 2011 |  |                |  | 13,923  |               |  |  | —                    |  |  |                       | — |  |                                                            |  |        |                                                                                 |  |  | —                                      |  |  |               | —
|Financial                       |  |                 |      |  |                |  |         |               |  |  |                      |  |  |                       |   |  |                                                            |  |        |                                                                                 |  |  |                                        |  |  |               |  
|Officer (2)                     |  |                 | 2010 |  |                |  | 68,521  |               |  |  | —                    |  |  |                       | — |  |                                                            |  | —      |                                                                                 |  |  | —                                      |  |  |               | —



|(1) | Mr. Hu Ye resigned as our Chief Financial Officer on December 1, 2010.          
|--- | --------------------------------------------------------------------------------
|(2) | Mr. Yongqiang Wang was appointed as Chief Financial Officer on December 1, 2010.



In 2011 fiscal year, the base salaries
of Messrs. Liu and Wang were decreased to provide additional cash flow for the Company so that it could lock in lower prices of
raw materials due to inflation in China. Messrs. Liu and Wang agreed to reduce their salaries to $18,564 and $13,923, respectively,
for fiscal year 2011 and executed addendums to their Employment Agreements to this effect (“2011 Addendums”).



In the Chief Financial Officer Employment
Agreement entered into on March 1, 2010 between the Company and Mr. Hu Ye, the Chief Financial Officer, the Company granted Mr.
Hu Ye an option to purchase 150,000 shares of common stock of the Company. The shares vest over 3 years starting March 1, 2010
and terminate on the third anniversary of the date of issuance of this option. The Company valued the shares at $5.20 per share,
which represents 130 % of the fair market value being calculated in the private placement price on May 15, 2007. The fair values
of stock options granted to the Chief Financial Officer were estimated at the date of grant with the following assumptions:



|Weighted average risk-free interest rate          |  |   | 2.79    | %
|------------------------------------------------- |  | - | ------- | -
|                                                  |  |   |         |  
|Expected term                                     |  |   | 3 years |  
|                                                  |  |   |         |  
|Expected volatility                               |  |   | 133     | %
|                                                  |  |   |         |  
|Expected dividend yield                           |  |   | 0       | %
|                                                  |  |   |         |  
|Weighted average grant-date fair value per option |  | $ | 3.00    |  



Grants of Plan-Based Awards in Fiscal 2008



On January 4, 2008, the Company adopted “Shengtai
Pharmaceutical, Inc. 2007 Stock Incentive Plan,” the “Stock Incentive Plan.”



In 2008, the Company granted 250,000 stock
options and 80,000 non-qualified stock options pursuant to the Stock Incentive Plan. All options have an exercise price of $6.60,
which is the closing price on the date of grant, and expire five years after the date of grant. All options vest over a period
of three years from the date of grant.



Outstanding Equity Awards at 2011 Fiscal Year End



As of June 30, 2011, there are 255,000 shares
of options outstanding.





2







Outstanding Equity Awards at June 30,
2011



|Name           |  | Option awards                                                           |         | Stock awards |                                                                          
|-------------- |  | ----------------------------------------------------------------------- | ------- | ------------ | -------------------------------------------------------------------------
|               |  | Number
    of securities underlying unexercised options (#) exercisable |         |              | Number of
    securities underlying unexercised options (#) unexercisable
|Qintai Liu     |  |                                                                         | 100,000 |              |                                                                          
|Yongqiang Wang |  |                                                                         | 10,000  |              |                                                                          



Option Exercises and Stock Vested in Fiscal 2011.



There were no options exercised and no stock
vested in 2011.



Employment Agreements



We have employment agreements with Qingtai
Liu, our chief executive officer, and with Yongqiang Wang , our Chief Financial Officer.



Compensation of Directors.



Our current non-executive directors are compensated
for all services they perform as directors, including attendance at Board of Directors meetings and service as members of committees
of the Board of Directors to which they are appointed. Executive officers are not compensated for services they perform as directors
of the Company.



The details of such compensation are:



| | • | Annual compensation of $22,500 to $30,000; and                                                                                                                    
| | - | ------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | • | we may also grant the non-executive directors certain options to purchase our shares, the amount and terms of which shall be determined by the Board of Directors.



The non-executive directors are also reimbursed
for all of their out-of-pocket expenses in traveling to and attending meetings of the Board of Directors and committees on which
they would serve.



The following table sets forth a summary
of compensation paid to our directors who are not listed in the Summary Compensation Table during the fiscal year ended June
30, 2011





3







|Name            |  | Fees earned or paid in cash ($) |        |  | Stock awards ($) |  |   | Option awards ($) |  |  | Non-equity incentive plan compensation ($) |  |  | Nonqualified deferred compensation earnings ($) |  |  | All other compensation
($) |  |   | Total ($) | 
|--------------- |  | ------------------------------- | ------ |  | ---------------- |  | - | ----------------- |  |  | ------------------------------------------ |  |  | ----------------------------------------------- |  |  | -------------------------- |  | - | --------- | 
|Winfred Lee (1) |  |                                 | 22,500 |  |                  |  | - |                   |  |  | 9,625                                      |  |  |                                                 |  |  |                            |  | - |           | 
|Yaojun Liu (2)  |  |                                 | 30,000 |  |                  |  |   |                   |  |  | 27,602                                     |  |  |                                                 |  |  |                            |  |   |           | 
|Fei He (3)      |  |                                 | 30,000 |  |                  |  |   |                   |  |  | 27,602                                     |  |  |                                                 |  |  |                            |  |   |           | 



| | (1) | Mr. Lee was granted 10,000 shares of stock options to purchase our shares.                                                                                                        
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | (2) | Mr. Liu was granted 40,000 shares of stock options to purchase our shares.                                                                                                        
| | (3) | Mr. He was granted 40,000 shares of stock options to purchase our shares.  Mr. He resigned from his position as director on August 20, 2011 and all of his options were forfeited.





4







PART IV



Item 15. Exhibits, Financial Statement Schedules



|(b) | Exhibits
|--- | --------



See Exhibit Index





5







SIGNATURES



Pursuant to the requirements of the Securities Exchange Act
of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacity and on the
date indicated.



|                    | SHENGTAI PHARMACEUTICAL, INC. |                              
|------------------- | ----------------------------- | -----------------------------
|                    | (Registrant)                  |                              
|                    |                               |                              
|Date: April 9, 2012 | By:                           | /s/ Qingtai Liu              
|                    |                               | Qingtai Liu                  
|                    |                               | Chief Executive Officer      
|                    |                               | (Principal Executive Officer)



| | By: | /s/ Yongqiang Wang                           | 
| | --- | -------------------------------------------- | 
| |     | Yongqiang Wang                               | 
| |     | Chief Financial Officer                      | 
| |     | (Principal Financial and Accounting Officer) | 



Pursuant to the requirements of the Securities
Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities
and on the dates indicated.



|Signature          |  | Title                                                                                                                                                 |  | Date         
|------------------ |  | ----------------------------------------------------------------------------------------------------------------------------------------------------- |  | -------------
|                   |  |                                                                                                                                                       |  |              
|/s/ Qingtai Liu    |  | Chief Executive
                                    Officer (Principal
        Executive Officer) and Director                                        |  | April 9, 2012
|Qingtai Liu        |  |                                                                                                                                                       |  |              
|                   |  |                                                                                                                                                       |  |              
|/s/ Yongqiang Wang |  | Chief Financial
                                    Officer (Principal Financial
        Officer, Principal Accounting Officer),
        and Director |  | April 9, 2012
|Yongqiang Wang     |  |                                                                                                                                                       |  |              
|                   |  |                                                                                                                                                       |  |              
|/s/ Yaojun Liu     |  | Director                                                                                                                                              |  | April 9, 2012
|Yaojun Liu         |  |                                                                                                                                                       |  |              
|                   |  |                                                                                                                                                       |  |              
|/s/ Tao Jin        |  | Director                                                                                                                                              |  | April 9, 2012
|Tao Jin            |  |                                                                                                                                                       |  |              
|                   |  |                                                                                                                                                       |  |              
|/s/ Lawrence Lee   |  | Director                                                                                                                                              |  | April 9, 2012
|Lawrence Lee       |  |                                                                                                                                                       |  |              





6







EXHIBIT INDEX



|Exhibit
        No. |  | Description                                                                                                                                                                                                                                                                                             
|------------------- |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|                    |  |                                                                                                                                                                                                                                                                                                         
|3.1                 |  | Amended and Restated Certificate of Incorporation as filed with the Secretary of State
    of the State of Delaware on March 10, 2004, as amended to date (incorporated by reference to Exhibit 3.1 to the registrant’s
    Form 10-SB filed on September 26, 2005 in commission file number 000-51312).
|                    |  |                                                                                                                                                                                                                                                                                                         
|3.2                 |  | Certificate of Amendment filed with Secretary of State of Delaware on November 9, 2010
    (incorporated by reference to Exhibit 99.1 to the registrant's Form 8-K filed on November 12, 2010).                                                                                                         
|                    |  |                                                                                                                                                                                                                                                                                                         
|3.3                 |  | Bylaws of the registrant (incorporated by reference to Exhibit 3.2 to the registrant’s
    Form 10-SB filed on September 26, 2005 in commission file number 000-51312).                                                                                                                                 
|                    |  |                                                                                                                                                                                                                                                                                                         
|4.1                 |  | Form of Warrants to Investors (incorporated by reference to Exhibit 4.1 to the registrant’s
    Form 8-K filed on May 21, 2007 in commission file number 000-51312) .                                                                                                                                   
|                    |  |                                                                                                                                                                                                                                                                                                         
|10.1                |  | Share Exchange Agreement dated May 15, 2007 by and among the Company and Shengtai Holding,
    Inc. (incorporated by reference to Exhibit 10.1 to the registrant’s Form 8-K filed on May 21, 2007 in commission file
    number 000-51312).                                                             
|                    |  |                                                                                                                                                                                                                                                                                                         
|10.2                |  | Share Purchase Agreement dated as of May 15, 2007 between the Company and the Purchasers
    (incorporated by reference to Exhibit 10.2 to the registrant’s Form 8-K filed on May 21, 2007 in commission file number
    000-51312).                                                                    
|                    |  |                                                                                                                                                                                                                                                                                                         
|10.3                |  | Research and Development Agreement between Hebei University and Technology of the Company,
    dated December 8, 2010. (incorporated by reference to Exhibit 10.3 to the registrant’s Form 10-K filed on October 6,
    2011 in commission file number 000-51312).                                      
|                    |  |                                                                                                                                                                                                                                                                                                         
|10.4                |  | Employment Agreement between the Company and Qingtai Liu, dated July 8 th , 2009 (incorporated
    by reference to Exhibit 10.4 to the registrant’s Form 10-K filed on October 6, 2011 in commission file number 000-51312).                                                                            
|                    |  |                                                                                                                                                                                                                                                                                                         
|10.5                |  | Employment Agreement between the Company and Yongqiang Wang, dated September 1st, 2009 (incorporated by reference to Exhibit 10.3 to the registrant’s Form 10-K/A filed on April 9, 2012 in commission
    file number 000-51312).                                                                      
|                    |  |                                                                                                                                                                                                                                                                                                         
|10.6                |  | 2010 Addendum between the Company and Qingtai Liu, dated June 30, 2010 (incorporated by
    reference to Exhibit 10.3 to the registrant’s Form 10-K/A filed on April 9, 2012 in commission file number 000-51312).                                                                                      
|                    |  |                                                                                                                                                                                                                                                                                                         
|10.7                |  | 2010 Addendum between the Company and Yongqiang Wang, dated June 30, 2010 (incorporated
    by reference to Exhibit 10.3 to the registrant’s Form 10-K/A filed on April 9, 2012 in commission file number 000-51312).                                                                                   
|                    |  |                                                                                                                                                                                                                                                                                                         
|10.8                |  | 2011 Addendum between the Company and Qingtai Liu, dated June 30, 2011*                                                                                                                                                                                                                                 
|                    |  |                                                                                                                                                                                                                                                                                                         
|10.9                |  | 2011 Addendum between the Company and Yongqiang Wang, dated June 30, 2011*                                                                                                                                                                                                                              
|                    |  |                                                                                                                                                                                                                                                                                                         
|16.1                |  | Letter dated October 20, 2009 from Moore Stephens Wurth Frazer and Torbet, LLP (incorporated
    by reference to Exhibit 16.1 to the registrant’s Form 8-K filed on October 21, 2009 in commission file number 000-51312).                                                                              
|                    |  |                                                                                                                                                                                                                                                                                                         
|21.1                |  | List of subsidiaries of the registrant (incorporated by reference to Exhibit 21.1 to the
    registrant’s Form 8-K filed on May 21, 2007 in commission file number 000-51312).                                                                                                                          
|                    |  |                                                                                                                                                                                                                                                                                                         
|31.1                |  | Certification of the Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a),
    as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*                                                                                                                                       
|                    |  |                                                                                                                                                                                                                                                                                                         
|31.2                |  | Certification of the Chief Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a),
    as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*                                                                                                                                      
|                    |  |                                                                                                                                                                                                                                                                                                         
|32.1                |  | Certification of the Chief Executive Officer pursuant to 18 U.S.C Section 1350, as adopted
    pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*                                                                                                                                              
|                    |  |                                                                                                                                                                                                                                                                                                         
|32.2                |  | Certification of the Chief Financial Officer pursuant to 18 U.S.C Section 1350, as adopted
    pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*                                                                                                                                              



* filed herewith





7